Circular of Fujian Provincial People’s Government on the Twelve Measures Concerning the Accelerated Development of Medicine Industry

Minzhengwen [2014] No. 98
From:Fujian Provincial People’s Government Date:2017-09-06【Font:large regular

Excerpts: The enterprises newly established by Global 100 or National 50 pharmaceutical manufacturers with the paid-in capital of 50 million RMB or above, or the headquarter enterprises or regional or functional head offices first introduced to Fujian Province, upon such verification, should be entitled to tax incentives based on their contribution to the local tax revenue, calculated from the same year of such verification. Such incentives should range between 60% and 80% for the first two years, and between 30% and 40% for the following three years. These enterprises or head offices may also be exempted from or refunded for their payment of the administrative fees which are within the local government’s authority, 100% for the first two years and 50% for the following three years.   

The senior managers and leading technicians working for the head offices of pharmaceutical manufacturers first introduced to Fujian Province, after being verified by competent authorities, may be granted allowances for accommodation and daily life, with the amount standing at 50% of the locally retained portion of personal income tax they pay at the locality the same year.  

The pharmaceutical manufacturers whose industrial outputs exceed 300 million, 500 million and 1 billion RMB for the first time should be awarded for 20%, 25% and 30% respectively of their incremental payments of the value added tax, the business tax and the corporate income tax combined over the previous year. The awards should be invested in the beneficiaries’ technology advancement or product research and development.  

The pharmaceutical manufacturers having participated in established specialized exhibitions inside or outside China and achieved substantial sales growths, with the industrial associations of the province as organizers, should be fully refunded by the Department of Commerce of Fujian Province for the expenditures on exhibition participation. In the event that a pharmaceutical manufacturer of the province bids for centralized procurement in another province other than Fujian Province and prevails with any single item whose contract amount stands at 20 million RMB or above, Fujian Provincial Commission of Economy and Information Technology should award the manufacturer for 1% of the incremental sales income over the previous year, up to 1 million RMB each enterprise. 

Share: